「september」の検索結果
12件：6～10件目を表示
-
General Announcement: September 6, 2024 Senju Pharmaceutical Co., Ltd. Launch of Distribution of Software for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906.pdf -
General Announcement: September 3, 2024 Senju Pharmaceutical Co., Ltd. Acquisition of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr....
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
General Announcement: September 3, 2024 Senju Pharmaceutical Co., Ltd. Acquisition of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr....
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
研发产品管线 | 研究与开发 | 千寿制药株式会社
） SJP-0170GlaucomaP3（Japan） SJP-0049Allergic ConjunctivitisP3（Japan） SJP-0154Dry eyeP2（Japan） As of September 2026
http://www.senju.co.jp/chinese/rd/pipeline.html -
お知らせ | 千寿製薬株式会社
ye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） September 4, 2025 Senju has developed and obtained approval for a BAC-free formulation of Aibeta® co...
http://www.senju.co.jp/english/news/